Funder: Eli Lilly and Company
Due Dates (Anticipated): June 2026 (proposal submission deadline, projected)
Funding Amounts: Support may include study drug and/or financial support; award size and duration vary by RFP and project scope.
Summary: Provides opportunities for external researchers to receive support for investigator-initiated clinical studies through competitive RFPs.